跳至主要内容
临床试验/NL-OMON27026
NL-OMON27026招募中不适用

Apixaban versus antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation. A randomised phase II clinical trial.

MC Utrecht0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Intracerebral haemorrhage, documented with CT or MRI, during treatment with anticoagulation (VKA, any direct thrombin inhibitor, any factor Xa inhibitor, or (low-molecular-weight) heparin at a therapeutic dose).
  • - The haemorrhage has occurred between 7 and 90 days before randomization.

排除标准

  • - Conditions other than atrial fibrillation for which the patient requires long-term anticoagulation.
  • - A different clinical indication for the use of an APD, such as clopidogrel for recent coronary stenting.

研究者

发起方
MC Utrecht

相似试验